Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,600 | -10,730 | -7,254 | -2,972 | -10,203 |
| Depreciation Amortization | 186 | 132 | 78 | 29 | 121 |
| Accounts receivable | -40 | -23 | -2 | -3 | 40 |
| Other Working Capital | -3,073 | -1,697 | 524 | 168 | -451 |
| Other Operating Activity | 5,944 | 781 | 467 | 124 | 702 |
| Operating Cash Flow | $-15,584 | $-11,537 | $-6,188 | $-2,654 | $-9,791 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39 | -39 | -36 | N/A | -2 |
| Net Acquisitions | -209 | 92 | 92 | N/A | N/A |
| Other Investing Activity | -425 | 0 | 0 | -250 | 0 |
| Investing Cash Flow | $-673 | $53 | $56 | $-250 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -291 | -262 | -232 | N/A | N/A |
| Common Stock Issued | 17,146 | 12,000 | 12,000 | 12,000 | 12,473 |
| Other Financing Activity | -1,785 | -1,719 | -1,719 | -1,115 | -1,618 |
| Financing Cash Flow | $15,071 | $10,019 | $10,049 | $10,885 | $10,855 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 495 |
| Beginning Cash Position | 7,363 | 7,363 | 7,363 | 7,363 | 5,806 |
| End Cash Position | 6,177 | 5,898 | 11,280 | 15,344 | 7,363 |
| Net Cash Flow | $-1,186 | $-1,465 | $3,917 | $7,981 | $1,557 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,584 | -11,537 | -6,188 | -2,654 | -9,791 |
| Capital Expenditure | -39 | -39 | -36 | N/A | -2 |
| Free Cash Flow | -15,623 | -11,576 | -6,223 | -2,654 | -9,792 |